These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

111 related articles for article (PubMed ID: 8260874)

  • 1. In vitro culture systems for hepatitis B and delta viruses.
    Sureau C
    Arch Virol Suppl; 1993; 8():3-14. PubMed ID: 8260874
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tissue culture system for infection with human hepatitis delta virus.
    Sureau C; Jacob JR; Eichberg JW; Lanford RE
    J Virol; 1991 Jul; 65(7):3443-50. PubMed ID: 2041075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. HBV and HDV replication in experimental models: effect of interferon.
    Caselmann WH
    Antiviral Res; 1994 Jul; 24(2-3):121-9. PubMed ID: 7526786
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Hepatitis B and D viruses replication interference: Influence of hepatitis B genotype.
    Madejón A; Romero M; Hernández Á; García-Sánchez A; Sánchez-Carrillo M; Olveira A; García-Samaniego J
    World J Gastroenterol; 2016 Mar; 22(11):3165-74. PubMed ID: 27003993
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Hepatitis D virus infection, replication and cross-talk with the hepatitis B virus.
    Huang CR; Lo SJ
    World J Gastroenterol; 2014 Oct; 20(40):14589-97. PubMed ID: 25356023
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The use of hepatocytes to investigate HDV infection: the HDV/HepaRG model.
    Sureau C
    Methods Mol Biol; 2010; 640():463-73. PubMed ID: 20645068
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Lack of HBV and HDV replicative activity in HBsAg-positive intravenous drug addicts with immune deficiency due to HIV.
    Monno L; Angarano G; Santantonio T; Milella M; Carbonara S; Fiore JR; Fico C; Pastore G
    J Med Virol; 1991 Jul; 34(3):199-205. PubMed ID: 1681028
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Humanized chimeric uPA mouse model for the study of hepatitis B and D virus interactions and preclinical drug evaluation.
    Lütgehetmann M; Mancke LV; Volz T; Helbig M; Allweiss L; Bornscheuer T; Pollok JM; Lohse AW; Petersen J; Urban S; Dandri M
    Hepatology; 2012 Mar; 55(3):685-94. PubMed ID: 22031488
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role of N glycosylation of hepatitis B virus envelope proteins in morphogenesis and infectivity of hepatitis delta virus.
    Sureau C; Fournier-Wirth C; Maurel P
    J Virol; 2003 May; 77(9):5519-23. PubMed ID: 12692255
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Mouse models of hepatitis B and delta virus infection.
    Dandri M; Lütgehetmann M
    J Immunol Methods; 2014 Aug; 410():39-49. PubMed ID: 24631647
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The hepatitis delta virus: Replication and pathogenesis.
    Sureau C; Negro F
    J Hepatol; 2016 Apr; 64(1 Suppl):S102-S116. PubMed ID: 27084031
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunoadhesins containing pre-S domains of hepatitis B virus large envelope protein are secreted and inhibit virus infection.
    Chai N; Gudima S; Chang J; Taylor J
    J Virol; 2007 May; 81(10):4912-8. PubMed ID: 17329331
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis D virus: an update.
    Pascarella S; Negro F
    Liver Int; 2011 Jan; 31(1):7-21. PubMed ID: 20880077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Quantitative longitudinal evaluations of hepatitis delta virus RNA and hepatitis B virus DNA shows a dynamic, complex replicative profile in chronic hepatitis B and D.
    Schaper M; Rodriguez-Frias F; Jardi R; Tabernero D; Homs M; Ruiz G; Quer J; Esteban R; Buti M
    J Hepatol; 2010 May; 52(5):658-64. PubMed ID: 20346531
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Co-expression of markers for hepatitis delta and hepatitis B viruses in human liver.
    Ryley NG; Heryet AR; Goldin R; Monjardino J; Saldanha J; Fleming KA
    Histopathology; 1992 Apr; 20(4):331-7. PubMed ID: 1577410
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficient inhibition of hepatitis B virus replication by hammerhead ribozymes delivered by hepatitis delta virus.
    Li X; Kuang E; Dai W; Zhou B; Yang F
    Virus Res; 2005 Dec; 114(1-2):126-32. PubMed ID: 16054262
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Persistent hepatitis D virus mono-infection in humanized mice is efficiently converted by hepatitis B virus to a productive co-infection.
    Giersch K; Helbig M; Volz T; Allweiss L; Mancke LV; Lohse AW; Polywka S; Pollok JM; Petersen J; Taylor J; Dandri M; Lütgehetmann M
    J Hepatol; 2014 Mar; 60(3):538-44. PubMed ID: 24280293
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The large form of hepatitis delta antigen is crucial for assembly of hepatitis delta virus.
    Chang FL; Chen PJ; Tu SJ; Wang CJ; Chen DS
    Proc Natl Acad Sci U S A; 1991 Oct; 88(19):8490-4. PubMed ID: 1924308
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new HDV mouse model identifies mitochondrial antiviral signaling protein (MAVS) as a key player in IFN-β induction.
    Suárez-Amarán L; Usai C; Di Scala M; Godoy C; Ni Y; Hommel M; Palomo L; Segura V; Olagüe C; Vales A; Ruiz-Ripa A; Buti M; Salido E; Prieto J; Urban S; Rodríguez-Frias F; Aldabe R; González-Aseguinolaza G
    J Hepatol; 2017 Oct; 67(4):669-679. PubMed ID: 28527664
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hepatitis B and D viruses exploit sodium taurocholate co-transporting polypeptide for species-specific entry into hepatocytes.
    Ni Y; Lempp FA; Mehrle S; Nkongolo S; Kaufman C; Fälth M; Stindt J; Königer C; Nassal M; Kubitz R; Sültmann H; Urban S
    Gastroenterology; 2014 Apr; 146(4):1070-83. PubMed ID: 24361467
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.